About Us
CELOXTM Medical (previously known as Medtrade) is a global med-tech company dedicated to the development and clinical advancement of patented lifesaving medical technologies and innovations across a wide range of applications including bleeding control, women’s health, advanced wound care and infection prevention. Established in the UK for over 25 years we manage the entire product development cycle to commercialisation through cutting edge research and development, advanced manufacturing, regulatory, clinical evaluation and marketing to provide an unparalleled and full service support for distribution partners across the world.
Our Mission
We dedicate ourselves to saving and improving people’s lives by stopping bleeding and supporting the healing of traumatic and chronic wounds through continual product innovation using patented and evidence-based technologies
Our Vision
To lead the industry in developing innovative and cutting-edge medical devices that are accessible, affordable and are a positive impact on global healthcare, whilst promoting sustainability
Powered by CELOX™ technology, a unique, patented and proprietary innovation, our clinical innovations have been developed to address significant areas of clinical need such as bleeding control, trauma management, women’s health, advanced wound care and major opportunities for future applications in biofilm control and infection prevention.
From battlefield to bedside CELOX™ brands have established a leading role in saving lives for nearly 20 years and developed global recognition in Trauma and Hospital patient management and more recently, with CELOX™ PPH, in helping to address the leading cause of maternal mortality worldwide, postpartum haemorrhage.
Our advanced wound care dressing portfolio consists of patented, innovative wound management solutions as a private label or under the AVARUS™ brand.
OMNI-STAT® powered by CELOX™ technology has provided a fast, safe and effective method for controlling minor, moderate and severe bleeding on a broad variety of wounds in various applications across the hospital.